Royal Philips will introduce a next-generation monitoring solution for at-risk patients in low acuity hospital settings, such as the general ward. Said solution includes a medical-grade biosensor that automatically and continuously measures vital signs such as heart rate, respiratory rate, skin temperature, single-lead ECG, posture and activity data. This, according to Philips, addresses both clinicians’ and patients’ needs through monitoring.
Once collected, the biosensor then transmits the data to a connected clinical decision support software, which can promptly notify caregivers or clinicians when preset limits are exceeded.
Philips plans to introduce a portfolio of integrated solutions which will connect to analytics tools and dashboards.“We see the potential for connected sensing solutions and the value created by the rich and actionable data they generate to have a very positive impact on the chronically ill by helping to reduce associated costly adverse events, complications, unplanned transfers back to the ICU and longer lengths of hospitalization,” Carla Kriwet, CEO Patient Care and Monitoring Solutions at Philips, said in a statement.
Philips plans to introduce a portfolio of integrated solutions which will connect to analytics tools and dashboards with the goal of helping clinicians improve patient outcomes, reduce costs, and improve access to care.
The company will be demonstrating its new monitoring solution at the 2016 Annual HIMSS Conference & Exhibition taking place Feb. 29 – March 4 at the Sands Expo in Las Vegas, Nevada.